OVARIAN CANCER METASTATIC RECURRENT
Clinical trials for OVARIAN CANCER METASTATIC RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER METASTATIC RECURRENT trials appear
Sign up with your email to follow new studies for OVARIAN CANCER METASTATIC RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug HWK-007 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called HWK-007 in people with advanced solid tumors, including certain ovarian, endometrial, and lung cancers. The drug is designed to target a protein (PTK7) found on cancer cells and deliver a chemotherapy-like payload directly to them. T…
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for ovarian cancer: targeted drug takes on resistant tumors
Disease control Recruiting nowThis study tests a new drug, trastuzumab deruxtecan (T-DXd), in people with recurrent ovarian cancer whose tumors have stopped responding to PARP inhibitors. T-DXd targets a protein called HER2 found on some cancer cells. The trial compares T-DXd to standard chemotherapy to see w…
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New hope for aggressive ovarian cancer: targeted drug combo enters trial
Disease control Recruiting nowThis study tests a new drug combination for people with a specific, high-risk type of ovarian cancer that has not yet been treated. The treatment includes a targeted drug (disitamab vedotin) plus standard chemotherapy and a blood-vessel blocker (bevacizumab). After initial treatm…
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated May 18, 2026 12:12 UTC